Sir John R. Vane – författare

Visar alla böcker från författaren Sir John R. Vane. Handla med fri frakt och snabb leverans.

9 produkter

Recent Advances in Prostaglandin, Thromboxane, and Leukotriene Research
Av Helmut Sinzinger, Bengt Samuelsson m. fl.
Inbunden, 1998
2236 kr
Lägg i varukorg
The International Symposium on Prostaglandins and Related Compounds, first held in Vienna 1972, revisited the city after 24 years for the 10TH Symposium. For the many re searchers working in this multi-disciplinary field it was an opportunity to exchange their ex periences and share new data with …
Recent Advances in Prostaglandin, Thromboxane, and Leukotriene Research
Av Patrick Y-K Wong, Peter Ramwell m. fl.
E-bok, 2013
2833 kr
Lägg i varukorg
The International Symposium on Prostaglandins and Related Compounds, first held in Vienna 1972, revisited the city after 24 years for the 10TH Symposium. For the many re searchers working in this multi-disciplinary field it was an opportunity to exchange their ex periences and share new data with …
Recent Advances in Prostaglandin, Thromboxane, and Leukotriene Research
Av Helmut Sinzinger, Bengt Samuelsson m. fl.
Häftad, 2013
2171 kr
Lägg i varukorg
The International Symposium on Prostaglandins and Related Compounds, first held in Vienna 1972, revisited the city after 24 years for the 10TH Symposium. For the many re searchers working in this multi-disciplinary field it was an opportunity to exchange their ex periences and share new data with …
Selective COX-2 Inhibitors
Pharmacology, Clinical Effects and Therapeutic Potential
Av Sir John R. Vane, Jack H. Botting
Häftad, 2012
1126 kr
Lägg i varukorg
The mainstay of therapy for rheumatoid disease is the non-steroid antiinflammatory drugs (NSAIDs), despite their inherent gastrointestinal toxicity and ability to cause renal damage in susceptible patients. The theory that the beneficial and toxic effects of NSAIDs stem from a reduction in …
New Targets in Inflammation
Inhibitors of COX-2 or Adhesion Molecules Proceedings of a conference held on April 15–16, 1996, in New Orleans, USA, supported by an educational grant from Boehringer Ingelheim
Av N. Bazan, Jack H. Botting m. fl.
Häftad, 2012
1126 kr
Lägg i varukorg
For the past 100 years the mainstay of therapy for rheumatoid arthritis (RA) has been aspirin or other drugs of the non-steroid anti-inflammatory group. In 1971 Vane pro posed that both the beneficial and toxic actions of these drugs was through inhibition of prostaglandin synthesis. The recent …
Improved Non-Steroid Anti-Inflammatory Drugs: COX-2 Enzyme Inhibitors
Av R.M. Botting, Jack H. Botting m. fl.
E-bok, 2012
1502 kr
Lägg i varukorg
In 1971, Vane proposed that the mechanism of action of the aspirin-like drugs was through their inhibition of prostaglandin biosynthesis. Since then, there has been intense interest in the interaction between this diverse group of inhibitors and the enzyme known as cyclooxygenase (COX). It exists …
Improved Non-Steroid Anti-Inflammatory Drugs: COX-2 Enzyme Inhibitors
Av Sir John R. Vane, Jack H. Botting m. fl.
Häftad, 2011
1126 kr
Lägg i varukorg
In 1971, Vane proposed that the mechanism of action of the aspirin-like drugs was through their inhibition of prostaglandin biosynthesis. Since then, there has been intense interest in the interaction between this diverse group of inhibitors and the enzyme known as cyclooxygenase (COX). It exists …
Selective COX-2 Inhibitors
Pharmacology, Clinical Effects and Therapeutic Potential
Av Jack H. Botting, Sir John R. Vane
E-bok, 2012
1502 kr
Lägg i varukorg
The mainstay of therapy for rheumatoid disease is the non-steroid antiinflammatory drugs (NSAIDs), despite their inherent gastrointestinal toxicity and ability to cause renal damage in susceptible patients. The theory that the beneficial and toxic effects of NSAIDs stem from a reduction in …
New Targets in Inflammation
Inhibitors of COX-2 or Adhesion Molecules Proceedings of a conference held on April 15–16, 1996, in New Orleans, USA, supported by an educational grant from Boehringer Ingelheim
Av Sir John R. Vane, Jack H. Botting m. fl.
E-bok, 2012
1455 kr
Lägg i varukorg
For the past 100 years the mainstay of therapy for rheumatoid arthritis (RA) has been aspirin or other drugs of the non-steroid anti-inflammatory group. In 1971 Vane pro posed that both the beneficial and toxic actions of these drugs was through inhibition of prostaglandin synthesis. The recent …